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Abstract
BACKGROUND: The predominant pattern of lung lesions in patients affected by coronavirus disease (COVID-
19) disease is diffuse alveolar damage with massive thromboembolism similar as described in patients infected 
with severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronaviruses. Hyaline 
membrane formation and pneumocyte atypical hyperplasia were frequent. Importantly, the formation of platelet–
fibrin thrombi in small vessels was seen consistent with coagulopathy, which appeared to be a common feature 
in patients who died of COVID-19. However, many were the cases found with similar COVID-19 symptomatology 
though negative results from nasal-pharyngeal swab performed by reverse transcription-polymerase chain reaction 
(RT-PCR). This latter typology of patients, otherwise named COVID-like, showed analogous clinical signs with similar 
arterial blood gas, cell blood count and laboratory parameters, and same computed tomography (CT)-scan ground-
glass opacities. Symptoms such as cough, fever, and difficulty breathing were highly similar as well. Both forms, 
COVID-19 and COVID-like, are primarily respiratory with multi-organ involvement and both revealed comparable 
incubation periods often with a rapid onset and unexpected decay. 
CASE REPORT: In this brief paper, we described two cases regarding two deceased males, one confirmed COVID-
19 (RT-PCR but not CT scan) and the second a COVID-like (negative for RT-PCR but positive to CT scan with 
ground-glass opacity) whom condition, disease patterns, and analysis were highly similar.
CONCLUSION: Improved investigation is mandatory, in which RT-PCR and CT scan procedures are completed by 
data from more detailed laboratory analysis, ABG analysis, BALF, and a deeper clinical assessment.
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Introduction
At the beginning of the current year, Italy 
was suddenly involved in the current coronavirus 
disease (COVID)-19 pandemics, and many thousands 
of patients have been recorded [1]. Nowadays, the 
main accepted procedure to confirm the positivity 
to COVID-19 is based on the nasopharyngeal swab 
analyzed by reverse transcription-polymerase chain 
reaction reverse transcription-polymerase chain 
reaction (RT-PCR). However, the limits of this procedure 
in diagnosing the disease are well known. The main 
issue is related to the low specificity of the procedure in 
verifying the presence of both false negatives and false 
positives; the second issue is due to mistakes related 
to the manual procedure by the health personnel; and 
third the possibility that virus has moved downward and 
settled within lungs, generating negative swab results. 
In addition, specimen tested without proper internal 
control could bias the results [2], [3], [4]. 
In our experience, the presence of COVID-
like patients represented an important number (n ≥ 60) 
(data not showed) and 2 patients out of 60 underwent 
bronchi-alveolar liquid test (bronchoalveolar lavage fluid 
[BALF]) resulting positive to severe acute respiratory 
syndrome coronavirus (SARS-CoV-2). Therefore, 
we do not exclude that among COVID-like patients 
may remain someone that was eventually infected by 
SARS-CoV-2 but resulted negative to the swab screen. 
Nevertheless, clinical and laboratory outcomes showed 
substantial similarities between SARS-CoV-2 and 
COVID-like patients which sharing pathophysiological 
features related to specific traits of severe and interstitial 
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pneumonia with clinical presentation greatly resembling 
each other’s [4], [5]. 
It follows that the RT-PCR negative results 
should not be conclusive of SARS-CoV-2 infection-free 
status and should not be used as solely indicator in the 
decision making treatment plan in suspected COVID-19 
cases. Hence, we proposed a new diagnostic protocol 
that eventually includes the clinical observations, 
patient history, BALF, blood, and specimen results with 
thoracic computed tomography (CT) scan essential in 
making the final conclusion.
It should be also added that SARS-CoV-2, with 
more than twenty million individuals infected worldwide, 
still remains unknown in many aspects, which 
includes the way the virus spreads and cooperates 
with other pathogens affecting the lungs and different 
organs such as heart, kidney, liver, and brain. In-fact, 
metatranscriptomic sequencing performed on BALF 
obtained from COVID-19 affected patients exposed a 
significant presence of bacteria highly similar to those 
found in patients affected by non-COVID-19 pneumonia. 
In addition to SARS-COV-2 infection, it was seen to 
contribute to the overall complications and worsening 
condition of patients with pre-existing comorbidities 
such as diabetes, cardiovascular disease, cancers, and 
kidney deficit, often leading to death [6], [7], [8], [9].
In this study, we prepared a comprehensive 
evaluation of two deceased patients; first patient 
(negative to swab-RT-PCR) admitted to 118 Pre-Hospital 
and Emergency Department of SG Moscati Hospital 
of Taranto City in Southern Italy, which is one of the 
designated hospitals assigned by Italian Government 
for patients severely or critically ill with COVID-19. The 
second patient was a confirmed COVID-19 (positive 
to swab-RT-PCR) admitted to Emergency Department 
and then moved to ICU Department of Civic Hospital 
of Cantu’ City in Northern Italy. We aimed to compare 
these two patients, COVID-19 and COVID-like, both 
presenting similar clinical features and symptomatology 
with tight superimposable laboratory and analysis 
findings, including arterial blood gas (ABG) results and 
cell blood count (CBC).
Case 1
The first case was a 51-year-old man, 
Caucasian admitted to 118 Emergency Hospital of 
SG Moscati Hospital in Taranto City, transported with 
“yellow code,” in April 24, 2020. The symptoms were 
dyspnea, tachypnea accompanied by fever, and 
general malaise that commenced between 19th and 
20th of April. At that time, the family Doctor prescribed 
steroids (betamethasone) and anti-histamines. The 
situation dramatically declined during the following days 
to the point had to be admitted into 118 Emergency 
Department (triage) in the early evening (20:00 pm), 
where he started receiving the adopted protocol of 
suspected COVID-19 composed of methylprednisolone, 
ceftriaxone, enoxaparin sodium, azithromycin, and 
oxygen therapy. 
Of note, the ABG analysis (ABG) assessed 
the presence of pH alkalosis, with hypoxia and 
hypocapnia. The CBC revealed a clinical characterized 
of neutrophilia and lymphopenia associated with high 
levels of inflammatory markers such as C-reactive 
protein (CRP), interleukin 6, D-dimer, and troponin with 
a low level of e-GFR and vitamin D. The nasopharyngeal 
swab analyzed by RT-PCR was negative and the CT 
scan showed the ground-glass opacity (Table 1).
At the beginning, the patient responded 
positively to the therapy and doctors assessed 
amelioration, the patient was aware, responsive, and 
attentive; the breathing was also better and, the fever 
sloped as well. The revised trauma scores were optimal 
confirmed by the Cincinnati Prehospital Stroke Scale 
that was normal. 
However, around 23:10 same evening, 
unexpectedly the patient’s condition suddenly worsened 
while he was moving to the Imaging Department to receive 
a CT scan (Figures 1a and b). Within a short time, the 
patient started showing symptoms of severe respiratory 
distress with hypotension, tachypnea, and hypoxemia 
and almost immediately entered into an irreversible 
comatose state. The electrocardiogram (ECG) performed 
at that time showed a sign of tachycardia with right axial 
deviation suggestive of ongoing respiratory distress and 
associated with an ongoing myocardial infarction (QRS-T 
complex) (Figure 2).
Figure 1: (a and b) Computed tomography scan of a coronavirus from 
a patient in SG Moscati showing ground-glass lesions in the lungs 
bilaterally soon before his situation worsened
The patients died soon after, the death was 
confirmed by the medical coroner at 00:10 AM of April 
25, 2020.
Autopsy examination and findings in case 1
Autopsy was performed in accordance with 
Italian NIH protocol and instruction. The whole procedure 
was completed in a thorough airborne infection isolation 
autopsy room with the use of appropriate protective 
tools and shields [10]. 
The trunk and abdomen were covered by 
hyperemic patches in a layer-like distribution. The heart 
presented few abnormal features described as follow: 
ba
Figure 2: The electrocardiogram (ECG) performed at the time of the admission showed tachycardia with a right axis deviation and evident 
problem in the ventricular repolarization mechanism. The precordial V1-V6 was suggestive of myocardial infarction in process. In general, the 
ECG has confirmed a key tool in prognostic value in coronavirus disease (COVID)-19 patients showing a variety of underlying cardiovascular 
conditions, such as hypertension, offering a particularly attractive methodology current COVID-19 pandemic [9]
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Globular shape and manifestly enlarged; abnormal 
condition of the oval foramen was seen as well; right atrial 
was enlarged and presented a concentrically hypertrophy 
of ipsilateral ventricle (thickness 1.2 cm); it was also seen 
the stenosis of pulmonary valve consequent of partial 
fusion of either right or left cuspid valves.
The lungs were found pleura-parietal and 
pleura-diaphragmatic adherent synechiae with 
modest pericardial serum effusion of about 100 cc. 
Upon macroscopic evaluation, the lungs were heavily 
congested and edematous. Bilaterally, the lower lobes 
showed topographies with dark-red colors consistently 
with hemorrhagic events, upper lobes were pink with 
atelectasis facets. Features were suggestive of an 
exudative and diffuse alveolar damage due to massive 
thromboembolism found in the right pulmonary 
artery with multiple occlusions of pulmonary arteries 
bilaterally mainly seen in the lower lobes. Thus, 
clots were located in the larger branches as well as 
in the periphery which means the clots were either 
thrombotic or embolic. It was confirmed the presence 
of aortic atherosclerosis. 
Case 2
The second case was an 86-year-old man, 
Caucasian admitted to 118 Emergency Unit of Civic 
Cantu’ Hospital in Cantu’ City Northern Italy. The patient 
was accepted in “yellow code,” in March 17, 2020, at 
15:37. The assessed symptoms were dyspnea (PaO2 
87%) with breathing difficulties, tachycardia, together 
with fever, asthenia, anosmia, and loss of appetite 
accompanied by diarrhea, the symptoms commenced 
March 10th. The patient was sent to receive CT scan and 
blood test analysis. The CT scan revealed multiple small 
patches of ground-glass opacities, while the blood count 
results were considered all within the normality ranges. 
The patient had a story of ischemic attack and benign 
prostate hyperplasia, he was under anti-coagulants 
and anti-prostatic medications, and he started receiving 
antibiotics ceftriaxone. The patient was reacting well to 
the first line of therapy and doctors assessed a slight 
amelioration, the patient was aware and attentive, the 
breathing was as well. However, at 18:37, the patient 
started worsening and was considered critical (PaO2 
67%); thus, he received the CPAP O2 mask. Later that 
night, condition decline further and CPAP was removed 
and an MV at 50% was instead positioned to the patient. 
The day after, March 18th, at 9:00 in the morning patient 
was considered non-responsive. Around 02:19 in the 
Table 1: The vital signs at the time of the entrance of patient n. 
1 (COVID-like)
Patient 1 male 51 years Vital signs – normal ranges CT scan RT-PCR swab
Arterial pulse 140/100 Ground glass negative
Body temp. 37.5°C
Heart rate 120/min
Respiratory rate 22.min
O2 sat. 85%
Glucose 119 mg/dL (74–100)
ABG pH 7.493 (7.35–7.45)
PO2 52.4 (75–100)
PCO2 25.3 (35–45)
eGFR 83,73 ml/min (>90) 
Total bilirubin 2.20 mg/dl (0.50)
Direct bilirubin 040 mg/dl (0.20)
Indirect bilirubin 180 mg/dl (0.30)
Fibrinogen 586 mg/dl (200–400)
Troponin 54.400 ng/L (<14)
CRP 28.2 mg/L (<3.5)
D-dimer 13.30 mg/L (<0.5)
25OH-vitamin D 23.1 ng/ml (>45)
IL-6 222.3 pg/ml (<7)
Total WBC 15.21 103/mm3 (3.59–10)
Neutrophilia 80.7% (35–75)
Lymphopenia 114% (20–55)
COVID: Coronavirus disease-19, CT: Computed tomography, RT-PCR: Reverse transcription-polymerase 
chain reaction, ABG: Arterial blood gas, CRP: C-reactive protein, IL-6: Interleukin. 
Figure 3: The electrocardiogram performed at the time of the admission showed sinus tachycardia with right atrial functionality. The precordial 
V1-V6 was indicative of myocardial infarction in process with ongoing angina. The patient died a few hours after for a massive severe 
cardiorespiratory collapse
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early morning of March 21st the patient was eventually 
assessed deceased. 
The vital signs at the time of the entrance 
were as follow
The patient was continuously monitored 
during the time of his hospitalization. The first total 
CBC performed March 11, 2020, showed only a few 
abnormal parameters (Table 2).
The CBC and vital signs at the entrance 
showed a not alarming situation, with an arterial pulse of 
160/90, no fever 36.3°C, the heart rate was acceptable 
with 120 b/min and respiratory rate 22/min. The patient 
was considered alert and responsive to stimuli; the 
revised trauma scores were normal; the Cincinnati 
Prehospital Stroke Scale was also normal (Table 2 for 
other levels and signs). However, the patients were 
saturating very low with an O2 level of 91% (AA), the 
ABG analysis confirmed a critical condition with typical 
signs of pH alkalosis 7.568, hypoxia PO2 30.5, and 
hypocapnia PCO2 18.1. The ECG performed at the time 
of admission confirmed a sinus tachycardia with typical 
signs of an ongoing MI prevalently seen in precordial 
V1-6 (QRS-T complex) (Figure 3). 
The second total CBC performed March 17, 
2020, showed a completely different clinical scenario 
all metabolic, chemistry, and inflammatory parameters 
were suggestive of a fast worsening condition (Table 2).
Thoracic CT scan
The CT scan findings of COVID-19 are those 
of atypical pneumonia or organizing pneumonia. 
Pulmonary hilar were congested and enlarged in 
appearance, it was seen a diffuse reticular-nodular with 
a parenchymal consolidation characterized by bilateral 
ground-glass opacities evidently the expression of 
active inflammation (Figure 4a and b).
Table 2: Results obtained from patient n.2 (COVID-19)
Patient 2 male 86 years Vital signs – normal range CT scan RT-PCR swab
First check 
Arterial pulse 160/90 Ground glass positive
Body temp. 36.3°C
Heart rate 120/min
Respiratory rate 22/min
O2 sat. 91
Glucose 115 mg/dL (74–100)
ABG pH 7.568 (7.35–7.45)
PO2 30.5 (75–100)
PCO2 18.1 (35–45)
eGFR 46.20 ml/min (>90) 
Creatine 1.15 mg/dl (0.6–1.3)
Chlorine 99 mEq/L
Second check Vital signs – normal range
Glucose 180 mg/Dl (74–100)
eGFR 37.1 ml/min (>90)
Fibrinogen 602 mg/dl (200–400)
Urea 81 mg/dl
Troponin 6337 ng/L (<14)
CRP 225.7 mg/L (<3.5)
Pro-BNP 18800 pg/ml (<450)
D-dimer 51977 ng/ml (<0.5)
p-PT/INR 1.55 (<1.1)
total WBC 20.16 10^3/mm3 (3.59–10)
Neutrophilia 89.9% (35–75)
Lymphopenia 5.3% (20–55)
Potassium 3.20 mEq/L (3.5–5.2)
AST 90 U/L (40)
ALT 57 U/L (55)
LDH 1095 U/l (100–245)
CPK 418 Ul/L (
CK-MB 11.70 ng/ml
COVID: Coronavirus disease-19, CT: Computed tomography, RT-PCR: Reverse transcription-polymerase 
chain reaction, ABG: Arterial blood gas, CRP: C-reactive protein, IL-6: Interleukin. 
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Discussion
Due to the rapid spread and the increasing 
number of COVID-19 infected patients, there is the 
need of more accurate evaluation of the virus to better 
control the sources of infection helping the population 
in preventing disease progression and spreading. 
Since December 2019, there have been considerable 
challenges especially in regarding the use of nucleic 
acid test (the nasal-pharyngeal swab by RT-PCR 
procedure), the CT scan, and the clinical physiognomies 
in trying to produce a standard orientation toward a 
more definitive diagnose of COVID-19 disease [11]. 
Nevertheless, at present, the diagnosis 
cornerstone remains in COVID-19 early-onset the 
positivity of RT-PCR and (only as secondary) the CT 
scan with the lung “ground glass” images and ABG 
analysis. This procedure would tend to exclude all those 
types of patients that we have titled COVID-like, which 
exhibit analogous symptoms and clinical picture of 
COVID-19 disease. The consequence of this diagnostic 
discrimination would eventually pose two fundamental and 
practical problems; first, the denial of having contracted 
the virus and thus being a potential contagious threat and 
second, the renunciation to consider the crucial results 
from the ABG and CT scan as predictive of more general 
worsening of the clinical condition due to virus infection. 
The COVID-19 and COVID-like patients share 
many features, they manifest low-intensity symptoms 
that usually aggravate shortly before the admission to 
the hospital, commencing with unnoticeable episodes 
of increasing respiratory difficulties. Furthermore, the 
COVID-19 and COVID-like patients show also similar 
clinical and laboratory patterns, low fever, dry cough, 
and medium intensity headache; the ABG analysis 
shows an alkalotic pH, with low PaO2 and low PaCO2, 
low lymphocytes, high neutrophils, high fibrinogen, 
high troponin, high CRP, high D-dimer, low eGFR, and 
high ESR. Apparently, both types of patients seem to 
respond well to the preliminary therapy approach, and 
both types of patients reveal a similar sudden and 
unexpected deteriorating process that may end-up to 
severe hypoxia, hypocapnia, MOF, and then death. 
In these short two case reports, our main aim 
was to highlight the similarities between COVID-19 
and COVID-like deceased. COVID-like and COVID-19 
share many common pattern of the infection much more 
than COVID-like would share with other pulmonary 
disease. Alarm has risen, especially after considering 
the deceptive good health of COVID-like individuals, 
which may become an exceptional contagious source. 
Important, the autopsy findings and post-mortem 
laboratory results performed on both COVID-19 and 
COVID-like deceased patients were all suggestive of a 
death consequent of an acute cardio-respiratory decay 
characterized by massive pulmonary thromboembolism 
accompanied by a considerable pulmonary hemorrhage 
as finally reported by few prominent published 
studies [13], [14], [15], [16]. 
Conclusion
While we are still learning and close to a 
second COVID-19 pandemic wave, there is still a 
lot that remains to be clarified about SARS-CoV-2. 
These short descriptive two case reports, which is 
just a part of wider and more extensive study yet to 
be published, are an attempt of comparing COVID-19 
and COVID-like disease as we strongly believe that 
it would be of great importance to identify patients at 
very high risk of mortality as a result of an overlapping 
of risk factors that were separately reported in patients 
who died from COVID-19 or COVID-like. Subjects 
aged ≥45–90 years and suffering from pre-existing 
comorbidities such as diabetes, cardiovascular 
diseases, or kidney disorders are likely to be the 
elective target of prevention and diagnostic activities. 
This is the reason why an improved investigation is 
mandatory, in which RT-PCR and CT scan procedures 
are completed by data from more detailed laboratory 
analysis, ABG analysis, BALF, and a deeper clinical 
assessment.
Consensus
This brief report received an official written 
consensus from the family of the deceased patients.
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